Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis
β Scribed by Carolin Lackner; Renate Moser; Thomas Bauernhofer; Martie Wilders-Truschnig; Hellmut Samonigg; Andrea Berghold; Kurt Zatloukal
- Book ID
- 110230407
- Publisher
- Springer US
- Year
- 1998
- Tongue
- English
- Weight
- 302 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In the present study, the expression and prognostic role of the CD44 splicing variants v5 and v6 were immunohistochemically investigated in 418 curatively resected gastric carcinomas. CD44v5 was expressed in 65β’3 per cent (n=273) and CD44v6 in 77β’0 per cent (n=322) of the tumours. Whereas the expres
Expression of CD44 and its variants is associated with clinically aggressive behavior of some human cancers. The present study was undertaken to determine the expression level of these CD44 mRNAs in relation to the clinicopathologic features and prognosis of gastric cancer. Using reverse transcripti